Jessica Hagen

Paul Grand, CEO of MedTech Innovator, discusses how the accelerator embraces high-risk, high-reward technologies and steers them to market with industry expertise.

The investment will accelerate Nexus IT’s U.S. expansion and support acquisitions of culturally aligned MSPs in healthcare and other regulated industries.

The two organizations will collaborate to accelerate the company's growth and enhance proactive care and management of chronic diseases.

Molly Gibson, president of future science at Lila Sciences, explains how the company's superintelligence will reshape research across life, chemical and material sciences.

The partners will develop and clinically validate an AI tool that integrates into EHRs to accelerate the diagnosis of hypophosphatasia, a rare genetic bone disorder.

Kidd's company will use 1,000 Bitcoin and additional cash to acquire the interest, and the former Ripple chief risk officer will become CEO and chairman of the board.

The company is offering 7.9 million of its common stock at an initial price of $19 per share, with shares trading under the ticker symbol OMDA.

Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.

The company will grow its clinical team and expand its offerings across GI partner clinics representing 700 physicians, after an 800% rise in patient volume.

The company aims to create a tech-driven, interoperable healthcare system that improves the patient experience while streamlining communication across brands.